Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Harvard Business School
Baxter
AstraZeneca
McKesson

Last Updated: August 15, 2022

Investigational Drug Information for Proflavine


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for Proflavine?

Proflavine is an investigational drug.

There have been 16 clinical trials for Proflavine. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2014.

The most common disease conditions in clinical trials are Neoplasms, Barrett Esophagus, and Uterine Cervical Neoplasms. The leading clinical trial sponsors are M.D. Anderson Cancer Center, Anandasabapathy, Sharmila, M.D., and William Marsh Rice University.

There are two hundred and sixty-nine US patents protecting this investigational drug and nine international patents.

Recent Clinical Trials for Proflavine
TitleSponsorPhase
Acceptability and Performance of a Mobile Optical Biopsy Technology for Gastrointestinal Cancer ScreeningBaylor College of MedicinePhase 2
Acceptability and Performance of a Mobile Optical Biopsy Technology for Gastrointestinal Cancer ScreeningUniversity of Sao PauloPhase 2
Acceptability and Performance of a Mobile Optical Biopsy Technology for Gastrointestinal Cancer ScreeningWilliam Marsh Rice UniversityPhase 2

See all Proflavine clinical trials

Clinical Trial Summary for Proflavine

Top disease conditions for Proflavine
Top clinical trial sponsors for Proflavine

See all Proflavine clinical trials

US Patents for Proflavine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Proflavine See Plans and Pricing Methods and devices for minimally-invasive delivery of radiation to the eye Salutaris Medical Devices, Inc. (Tucson, AZ) See Plans and Pricing
Proflavine See Plans and Pricing Synergistic compositions for treating microbial infections University of Rochester (Rochester, NY) Temple University--Of the Commonwealth System of Higher Education (Philadelphia, PA) See Plans and Pricing
Proflavine See Plans and Pricing Strip package for antiseptic cap Excelsior Medical Corporation (San Clemente, CA) See Plans and Pricing
Proflavine See Plans and Pricing Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid MERCK & CIE (Schaffhausen, CH) See Plans and Pricing
Proflavine See Plans and Pricing Amylases, nucleic acids encoding them and method of producing an oil BASF ENZYMES LLC (San Diego, CA) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Proflavine

Drugname Country Document Number Estimated Expiration Related US Patent
Proflavine China CN107208158 2035-02-27 See Plans and Pricing
Proflavine European Patent Office EP3262192 2035-02-27 See Plans and Pricing
Proflavine Spain ES2836802 2035-02-27 See Plans and Pricing
Proflavine World Intellectual Property Organization (WIPO) WO2016138496 2035-02-27 See Plans and Pricing
Proflavine Australia AU2018289077 2037-06-23 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Harvard Business School
Baxter
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.